13F

Stock

Alnylam Pharmaceuticals, Inc.

ALNY · held by 10 managers

Reported value

$45M

Holders

10

+2 new · −0 exited

Holders’ est. mark

$10.6M

Price effect on 5 books still in the name

Largest holder

$26.5M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC2.05M$26.5M$12.9MCut−$8.43M
DANSKE BANK A/S62K$14.6M−$2.08MAdded$179.3K
Swiss Life Asset Management Ltd12.8K$3.01M−$143.4KAdded$2.02M
ONTARIO TEACHERS PENSION PLAN BOARD1.55K$364KNew
Marex Group plc1.27K$298.4KNew
Prestige Wealth Management Group LLC316$74.4K−$12.6KCut−$49.7K
Evelyn Partners Investment Management LLP250$58.8KHeld
Leonteq Securities AG147$34.6K−$3.77KAdded$8.46K
Aventura Private Wealth, LLC30$7.06KHeld

Positions as of Q4 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.